Group 1: Market Overview - The market is experiencing a "micro-dip," which is viewed as a healthy pause in a strong bull market, providing opportunities for long-term investors to buy at better prices [1] - Resilient stocks during market corrections are likely to emerge as future leaders, making them attractive for investment [2] Group 2: Stock Analysis - Celsius (CELH) has shown a significant recovery after a valuation reset, with sales expected to surge by 75% this year and 25% in 2026, alongside a 34.6% increase in FY25 earnings estimates [5][6] - CommScope (COMM) is gaining attention as a player in AI infrastructure, with earnings projected to grow by 23.8% annually over the next three to five years, and a Zacks Rank of 1 indicating strong buy sentiment [9][10] - Stride (LRN) operates in the education sector, with a Zacks Rank of 1 and earnings estimates raised by up to 12% in the last month, while profits are expected to grow at a 20% annual rate [12][14] Group 3: Investment Sentiment - The three highlighted stocks—Celsius, CommScope, and Stride—combine strong fundamentals, favorable analyst sentiment, and supportive technicals, making them compelling opportunities for investment [17]

Core Insights - Verizon Communications Inc. and AT&T, Inc. are major players in the U.S. telecommunications industry, providing a wide range of communication services to various customer segments [1] - The U.S. telecom services market is projected to grow at a 6.6% CAGR from 2024 to 2030, with the Fiber to the home market expected to increase from $10.7 billion to $21.5 billion by 2030, reflecting a CAGR of 12.7% [2] AT&T Analysis - AT&T is modernizing its network infrastructure to capitalize on the 5G boom, driven by high-end applications such as AI, IoT, and C-V2X [3] - The company plans to deploy a nationwide mobile 5G network using millimeter wave spectrum in dense areas and mid- and low-band spectrum in suburban and rural regions, reaching 30 million locations with its fiber broadband network [4] - AT&T is collaborating with Ericsson to implement an Open RAN architecture, aiming for 70% of its wireless network traffic to utilize open-capable platforms by late 2026 [5] - The partnership with Microsoft will transition AT&T's 5G core to the cloud, enhancing productivity and service delivery [6] - Despite these advancements, AT&T faces intense competition from T-Mobile and Verizon, which could impact its margins [7] Verizon Analysis - Verizon is enhancing its 5G Ultra-Wideband coverage through extensive spectrum holdings, deep fiber resources, and small cell deployment [9][10] - The company employs a customer segmentation strategy to provide tailored solutions, which aids in client retention and revenue growth [11] - Verizon's high capital expenditures for 5G and fiber infrastructure may pressure margins, and the competitive landscape limits pricing flexibility [12] - The introduction of advanced use cases, such as the Edge Transportation Exchange for connected vehicles, aims to create new revenue streams [13] Financial Estimates - The Zacks Consensus Estimate for Verizon's 2025 sales and EPS indicates year-over-year growth of 2.51% and 2.4%, respectively, with upward revisions noted [14] - For AT&T, the 2025 sales estimate suggests a growth of 2.16%, while EPS is projected to decline by 9.29%, although estimates have trended upward [16] Price Performance & Valuation - Over the past year, Verizon's stock has increased by 9.6%, while AT&T has seen a gain of 50.8% [17] - Verizon's shares trade at a forward P/E ratio of 9.28, which is lower than AT&T's 13.41, indicating a more attractive valuation for Verizon [17] Conclusion - Both companies are rapidly enhancing their 5G and fiber broadband capabilities, but AT&T's customer-centric approach and strategic collaborations may provide a competitive edge in the postpaid wireless market [21]

Company Overview - Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company focused on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system diseases [6] - The company's portfolio includes innovative programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis [6] Alzheimer's Disease Therapeutic Development - Silo Pharma announced the publication of preclinical research for its Alzheimer's disease therapeutic, SPC-14, in the journal Alzheimer's Research & Therapy [1] - The study titled "Combinatorial targeting of NMDARs and 5-HT4Rs exerts beneficial effects in a mouse model of Alzheimer's disease" indicates that the combined administration of (R,S)-ketamine with prucalopride is a novel multi-modal therapeutic strategy to treat cognitive decline in Alzheimer's disease [2] - The results showed that the SPC-14 formulation improved cognitive decline by increasing memory retrieval in a fear conditioning model in mice, identifying SPC-14 as a promising drug combination for therapeutic use in Alzheimer's disease [3] Market Potential - The Alzheimer's disease treatment market is projected to grow to $30.8 billion by 2033, with a compound annual growth rate (CAGR) of 18.8% [4] - SPC-14 was developed under a sponsored research agreement with Columbia University, and Silo Pharma entered into an exclusive global license agreement with the university to further develop, manufacture, and commercialize SPC-14 [4] Therapeutic Mechanism - SPC-14 is a novel intranasal therapeutic that targets glutamate receptor NMDAR and serotonin type 4 receptor 5HT4 to treat cognitive and neuropsychiatric symptoms in Alzheimer's disease [5] - In preclinical studies, SPC-14 was effective against luteinizing hormone stress, attenuating learned helplessness, perseverative behavior, and hyponeophagia, which is a measure of anxiety [5]

Core Viewpoint - NorthEast Community Bancorp, Inc. has declared a special cash dividend of $0.20 per share, reflecting its commitment to enhancing shareholder value [1][2]. Company Overview - NorthEast Community Bancorp is headquartered in White Plains, New York, and serves as the holding company for NorthEast Community Bank, which operates eleven branch offices across New York and Massachusetts [2]. Dividend Details - The special cash dividend will be paid on or about October 6, 2025, to shareholders of record as of the close of business on September 8, 2025 [1]. - This marks a continuation of the company's strategy to provide returns to shareholders through dividends [2]. Leadership Statement - Kenneth A. Martinek, Chairman and CEO, expressed satisfaction in being able to pay a special dividend, emphasizing the company's long-term commitment to shareholder value [2].

Core Insights - Silo Pharma, Inc. announced the publication of preclinical research for its Alzheimer's disease therapeutic, SPC-14, in a leading scientific journal, Alzheimer's Research & Therapy [1][2] - The study indicates that the combination of (R,S)-ketamine and prucalopride is a novel therapeutic strategy for treating cognitive decline in Alzheimer's disease [2] - SPC-14 has shown promising results in improving cognitive decline in preclinical models, suggesting its potential as a therapeutic option for Alzheimer's disease [3] Company Overview - Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company focused on addressing underserved conditions, including Alzheimer's disease [5] - The company has developed SPC-14 under a sponsored research agreement with Columbia University and has an exclusive global license to further develop and commercialize the product [4] - Silo's portfolio includes other innovative programs targeting conditions such as PTSD and chronic pain, indicating a broad therapeutic focus [5] Market Potential - The Alzheimer's disease treatment market is projected to grow to $30.8 billion by 2033, with a compound annual growth rate (CAGR) of 18.8% [4][7] - SPC-14 targets glutamate receptor NMDAR and serotonin type 4 receptor 5HT4, addressing cognitive and neuropsychiatric symptoms associated with Alzheimer's disease [4]

Core Points - NorthEast Community Bancorp, Inc. has declared a special cash dividend of $0.20 per share on its outstanding common stock, to be paid on or about October 6, 2025, to shareholders of record as of September 8, 2025 [1][2] - The Chairman and CEO, Kenneth A. Martinek, emphasized that the payment of dividends reflects the company's long-term commitment to enhancing shareholder value [2] Company Overview - NorthEast Community Bancorp is headquartered in White Plains, New York, and serves as the holding company for NorthEast Community Bank, which operates eleven branch offices across New York and Massachusetts [2] - The bank has branch locations in Bronx, Orange, Rockland, and Sullivan Counties in New York, as well as Essex, Middlesex, and Norfolk Counties in Massachusetts, along with three loan production offices [2]

Core Insights - TEGNA Inc. has appointed Brent Denny as president and general manager of WTHR and WALV in Indianapolis, effective immediately, with a focus on financial performance and business strategy [1][9] Group 1: Leadership and Experience - Brent Denny brings over 30 years of broadcast experience, having spent the last 11 years at WTHR/WALV in various senior roles, most recently as director of sales, where he significantly contributed to revenue growth and advertiser relationships [2] - Prior to his tenure at WTHR/WALV, Denny held multiple leadership positions at WISH-TV/WNDY in Indianapolis for over eight years, focusing on strategy, planning, forecasting, and budgeting [3] Group 2: Community and Vision - Larry Delia, senior vice president at TEGNA, praised Denny's talent and ability to foster collaboration and community relationships, expressing confidence in his leadership at WTHR/WALV [4] - Denny expressed his commitment to maintaining the legacy of WTHR/WALV as a news leader in Indianapolis while exploring new ways to serve the community [4] Group 3: Company Overview - TEGNA Inc. operates 64 television stations across 51 U.S. markets, reaching over 100 million people monthly through various platforms, emphasizing its role in providing trusted local news and services [5]

Equity Research Analyst at DM Martins Research.The best opportunities often don’t scream for attention. I cover stocks that are often undercovered, focusing primarily on Brazil and Latin America — but I also occasionally write about global large caps. My work can also be found on TipRanks, where I contribute regularly, and on TheStreet, where I was a frequent contributor in the past.- Disclaimer: All views expressed here are my own and do not necessarily reflect the views or official positions of DM Martins ...

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lantheus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Au ...

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fluor and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On August 1, 2025, F ...